Innovating Point-of-Care Molecular Diagnostics
Cubit Diagnostics is redefining rapid molecular testing with a low-cost, multimodal, compact, user-friendly platform designed for decentralized healthcare environments.
Project overview
Arete partnered with Cubit Diagnostics from its earliest concept phase—investing seed capital, defining the product strategy, and leading development to transform a benchtop assay into a fully integrated point-of-care system in just 18 months.
Integrated Platform Development
Seed-Stage Venture Support
System Engineering & Strategy
Key Achievements
From Assay Concept to Functional POC System in 18 Months
Arete provided end-to-end support across assay integration, industrial design, system engineering, and regulatory strategy—culminating in a first-gen working platform and the launch of second-gen development under the NIH RADx program.
Key Achievement
Delivered a functional first-generation POC system with cartridge, instrument, and workflow integration—enabling initial usability testing and design verification planning.
Client Impact
Cubit successfully advanced to second-gen development under RADx funding, with a clear path toward clinical trials and broader investor and partner engagement.
.webp)
Performance, usability, and cost are the pillars of our design. From the start, we worked with Arete to engineer our microfluidic system to enable high-sensitivity molecular and immunoassay testing at a fraction of the cost of today’s lab systems.
Kunal Sur
CEO
